3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Stomach Neoplasms
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Urogenital Neoplasms
2
Triple Negative Breast Neoplasms
2
Rectal Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Melanoma
2
Gastrointestinal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Osteosarcoma
1
Neuroendocrine Tumors
1
Myelodysplastic Syndromes
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Histiocytoma, Malignant Fibrous
1
Hematologic Neoplasms
1
Giant Cell Tumor of Bone
1
Interventions
Whole-Body Irradiation
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Methotrexate
3
Cytarabine
3
venetoclax
2
ponatinib
2
merphos
2
fludarabine phosphate
2
Tacrolimus
2
Idarubicin
2
Etoposide
2
Cyclosporine
2
Cyclophosphamide
2
Cladribine
2
Busulfan
2
nilotinib
1
midostaurin
1
gilteritinib
1
bosutinib
1
blinatumomab
1
asciminib
1
Thiotepa
1
Sirolimus
1
Razoxane
1
N,N-dicyclohexyl-isoborneol-10-sulfonamide
1
Melphalan
1
Injections
1
Imatinib Mesylate
1
Gemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Blast Crisis
×
aldesleukin
×
30 days
×
Clear all
No trials found.